GO:0018885 carbon tetrachloride metabolic process: Xenobiotic Biotransformation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0018885 carbon tetrachloride metabolic process describes the chemical reactions and pathways involving carbon tetrachloride (CCl4), a toxic and carcinogenic industrial solvent and grain fumigant.
• The dominant initiating event is reductive dehalogenation catalyzed by cytochrome P450 enzymes, generating the highly reactive trichloromethyl radical (CCl3•).
• The trichloromethyl radical drives lipid peroxidation, protein adduct formation, and hepatocellular injury, making CCl4 a classic experimental hepatotoxin.
• CCl4 metabolism is not restricted to mammals; it also occurs in plants and under anaerobic sulfate-reducing conditions, indicating broad environmental and biological relevance.
• CCl4-induced injury is modulated by host metabolic status, including adipokine signaling such as lipocalin-2, which can influence fibrosis outcomes.
• CCl4 exposure also causes extrahepatic damage, including ovarian oxidative stress and inflammatory fibrosis, expanding its toxicological footprint beyond the liver.
Description
Carbon tetrachloride (CCl4) is a volatile, lipophilic halogenated hydrocarbon that has been widely used as an industrial degreasing solvent, a grain fumigant, and a chemical intermediate in refrigerant production. Because of its toxicity and carcinogenicity, its industrial use has been restricted, but it remains a cornerstone experimental agent for studying xenobiotic metabolism and chemically induced organ injury. The Gene Ontology term GO:0018885, carbon tetrachloride metabolic process, captures the biochemical reactions and pathways that transform this compound within living systems. Understanding this process is essential for toxicology, pharmacology, and environmental biotechnology, because the metabolic intermediates formed from CCl4 are often more reactive and damaging than the parent molecule. Research on GO:0018885 spans multiple biological contexts. In mammals, hepatic cytochrome P450 enzymes reductively dehalogenate CCl4 to a trichloromethyl radical that initiates lipid peroxidation and covalent binding to cellular macromolecules. In plants, poplar cells can aerobically transform CCl4, demonstrating that non-animal systems also possess relevant metabolic capacity. Under sulfate-reducing conditions, microbial communities transform CCl4, highlighting anaerobic biodegradation pathways relevant to environmental remediation. These diverse contexts make GO:0018885 a useful framework for comparing xenobiotic metabolism across species and environmental niches. The term also has direct translational importance. CCl4 exposure is a standard model for acute and chronic liver injury, hepatic fibrosis, and oxidative stress research. More recently, studies have shown that CCl4 can induce ovarian damage through oxidative stress and inflammatory fibrosis, and that host factors such as lipocalin-2 can modulate fibrotic responses in metabolically compromised animals. Thus, GO:0018885 connects fundamental radical chemistry to organ-specific pathology and to the discovery of protective or sensitizing genetic modifiers.
carbon tetrachloride metabolic process At A Glance
| GO ID | GO:0018885 |
|---|---|
| GO term | carbon tetrachloride metabolic process |
| Ontology | biological_process |
| Synonym | carbon tetrachloride metabolism |
| Definition | The chemical reactions and pathways involving carbon tetrachloride, a toxic, carcinogenic compound used as a general solvent in industrial degreasing operations, as a grain fumigant, and as a chemical intermediate in the production of refrigerants. |
| Major function | Biotransformation and detoxification or bioactivation of the xenobiotic carbon tetrachloride, generating reactive radical intermediates and downstream oxidative damage. |
| Key initiating enzymes | Cytochrome P450 enzymes, particularly hepatic isoforms that catalyze reductive dehalogenation. |
| Characteristic intermediate | Trichloromethyl radical (CCl3•), which drives lipid peroxidation and covalent adduct formation. |
| Representative experimental models | Rodent liver injury models, ob/ob mice, rat ovarian injury models, poplar cell cultures, and sulfate-reducing microbial communities. |
What Is GO:0018885?
GO:0018885 carbon tetrachloride metabolic process is defined by the Gene Ontology as the chemical reactions and pathways involving carbon tetrachloride, a toxic, carcinogenic compound used as a general solvent in industrial degreasing operations, as a grain fumigant, and as a chemical intermediate in the production of refrigerants. In practical terms, it encompasses the enzymatic and non-enzymatic steps that convert CCl4 into reactive intermediates, stable metabolites, and macromolecule-bound adducts, as well as the downstream biochemical consequences of those transformations.
Why Is carbon tetrachloride metabolic process Important in Cell Biology?
GO:0018885 is important because carbon tetrachloride metabolism sits at the intersection of xenobiotic bioactivation, oxidative stress, and organ-specific toxicity. The reductive dehalogenation of CCl4 by cytochrome P450 enzymes produces a reactive trichloromethyl radical that initiates lipid peroxidation and covalent binding to proteins and lipids, making this pathway a textbook example of metabolic activation. Because CCl4 is still used experimentally to model acute and chronic liver injury, understanding its metabolic process is essential for interpreting hepatotoxicity data and for developing protective strategies. The term also matters beyond the liver: CCl4 exposure can damage the ovary through oxidative stress and inflammatory fibrosis, and host metabolic factors such as lipocalin-2 can modify fibrotic outcomes. Finally, CCl4 transformation occurs in plants and anaerobic microbial communities, giving GO:0018885 environmental and biotechnological significance for bioremediation research.
• Provides a mechanistic framework for CCl4-induced hepatotoxicity, one of the most widely used experimental models of liver injury.
• Explains how cytochrome P450-mediated reductive dehalogenation bioactivates CCl4 into a reactive trichloromethyl radical.
• Links xenobiotic metabolism to lipid peroxidation, protein adduct formation, and oxidative stress.
• Relevant to hepatic fibrosis research, including modulation by adipokines such as lipocalin-2 in ob/ob mice.
• Extends to extrahepatic toxicity, including ovarian oxidative stress and inflammatory fibrosis after CCl4 exposure.
• Supports environmental biotechnology through aerobic transformation in poplar cells and anaerobic transformation under sulfate-reducing conditions.
• Helps interpret species differences in xenobiotic metabolism and susceptibility to halogenated hydrocarbon toxicity.
• Guides discovery of hepatoprotective agents, such as plant-derived extracts tested against CCl4-induced injury.
• Informs risk assessment for occupational and environmental exposure to chlorinated solvents.
• Connects metabolic reprogramming and mitophagy in hepatic stellate cells to fibrosis progression in CCl4 models.
What Happens During carbon tetrachloride metabolic process?
Phase I Reductive Dehalogenation by Cytochrome P450
In simple terms: The liver's detoxification enzymes grab electrons and strip a chlorine atom from carbon tetrachloride, creating a highly reactive radical.
The initiating step of carbon tetrachloride metabolic process is reductive dehalogenation, in which cytochrome P450 enzymes catalyze the transfer of electrons to CCl4, producing the trichloromethyl radical (CCl3•) and chloride. Studies using hepatic microsomes showed that metabolic activation of CCl4 is associated with an apparent loss of cytochrome P-450, indicating that the enzyme itself is damaged during turnover. This bioactivation step is central to the toxicological profile of CCl4 because the resulting radical is far more reactive than the parent compound.
Radical-Mediated Lipid Peroxidation
In simple terms: The reactive radical attacks fats in cell membranes, setting off a chain reaction that damages the cell.
Once formed, the trichloromethyl radical can abstract hydrogen atoms from polyunsaturated fatty acids in membrane lipids, initiating lipid peroxidation. This chain reaction generates lipid radicals and breakdown products such as malondialdehyde, which propagate oxidative damage and compromise membrane integrity. Lipid peroxidation is a hallmark of CCl4 hepatotoxicity and is widely measured as a biomarker of GO:0018885 activity in experimental models.
Covalent Binding to Cellular Macromolecules
In simple terms: The radical sticks to proteins and lipids, forming permanent chemical adducts that disrupt normal cell function.
In addition to lipid peroxidation, the trichloromethyl radical and its peroxy derivative can covalently bind to proteins, lipids, and nucleic acids, forming stable adducts. This covalent binding is thought to contribute to enzyme inactivation, loss of membrane function, and hepatocellular necrosis. The extent of covalent binding correlates with the severity of CCl4-induced injury in experimental systems.
Aerobic Transformation in Plant Systems
In simple terms: Plants can also break down carbon tetrachloride, using oxygen-dependent reactions rather than the radical chemistry seen in the liver.
Carbon tetrachloride metabolic process is not limited to animals. Poplar cells were shown to aerobically transform CCl4, indicating that plant systems possess enzymatic or non-enzymatic pathways capable of metabolizing this halogenated compound. This finding broadens the biological scope of GO:0018885 and supports the use of plant-based systems for phytoremediation research.
Anaerobic Transformation Under Sulfate-Reducing Conditions
In simple terms: In oxygen-free environments, certain bacteria can also transform carbon tetrachloride, which is important for cleaning up contaminated groundwater.
Under sulfate-reducing conditions, microbial communities transform CCl4 through reductive pathways that differ from aerobic metabolism. These anaerobic transformations are relevant to bioremediation of contaminated sediments and groundwater, where oxygen is limited. Together with plant-based aerobic transformation, this demonstrates that GO:0018885 encompasses diverse environmental and microbial metabolic routes.
Downstream Cellular Responses and Fibrosis
In simple terms: After the initial damage, the liver activates repair and inflammatory programs that can lead to scarring if injury persists.
The oxidative stress and macromolecular damage generated by CCl4 metabolism trigger inflammatory and fibrogenic responses. In the liver, hepatic stellate cells become activated and undergo metabolic reprogramming, with AMPK and mitophagy implicated in sustaining their activated state. In metabolically compromised ob/ob mice, CCl4 did not promote hepatic fibrosis in the same way as in lean animals, and this effect was linked to downregulation of lipocalin-2 protein. These findings illustrate how the consequences of GO:0018885 depend on host genetic and metabolic context.
Key Genes Involved in GO:0018885 carbon tetrachloride metabolic process
The following genes and proteins have been experimentally implicated in carbon tetrachloride metabolic process or in the cellular responses to its reactive metabolites, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP2E1 | Cytochrome P450 isoform that reductively dehalogenates CCl4 to the trichloromethyl radical | Central to mechanistic studies of CCl4 bioactivation and hepatotoxicity |
| CYP2B1/2B2 | Cytochrome P450 isoforms contributing to CCl4 metabolic activation in rodent liver | Used to model species and isoform differences in xenobiotic metabolism |
| CYP3A | Cytochrome P450 subfamily with potential roles in halogenated hydrocarbon metabolism | Candidate for comparative studies of CCl4 bioactivation |
| LCN2 | Lipocalin-2, an adipokine that modulates fibrotic responses after CCl4 exposure | Explains resistance to CCl4-induced fibrosis in ob/ob mice |
| AMPK | Energy sensor kinase that maintains hepatic stellate cell activation via mitophagy-induced metabolic reprogramming | Links CCl4-induced fibrosis to cellular metabolism |
| COL1A1 | Type I collagen alpha-1 chain, a marker of fibrogenesis | Readout of CCl4-induced hepatic fibrosis |
| ACTA2 | Alpha-smooth muscle actin, a marker of activated hepatic stellate cells | Used to quantify myofibroblast activation after CCl4 injury |
| TGFB1 | Transforming growth factor beta-1, a profibrotic cytokine | Central mediator of fibrosis downstream of CCl4 injury |
| NFE2L2 | NRF2, a transcription factor controlling antioxidant responses | Modulates cellular defense against CCl4-derived oxidative stress |
| HMOX1 | Heme oxygenase-1, an antioxidant enzyme | Marker of oxidative stress response after CCl4 exposure |
| GPX1 | Glutathione peroxidase 1, detoxifies lipid peroxides | Protects against CCl4-induced lipid peroxidation |
| CAT | Catalase, decomposes hydrogen peroxide | Contributes to antioxidant defense during CCl4 metabolism |
| SOD1 | Superoxide dismutase 1, converts superoxide to hydrogen peroxide | Part of the antioxidant network engaged by CCl4 |
| IL6 | Interleukin-6, an inflammatory cytokine | Mediates inflammatory responses after CCl4 exposure |
| TNF | Tumor necrosis factor, a pro-inflammatory cytokine | Contributes to CCl4-induced tissue injury |
| BECN1 | Beclin-1, a core autophagy regulator | Implicated in mitophagy and stellate cell activation after CCl4 |
| PRKAA1 | Catalytic subunit of AMPK | Required for metabolic reprogramming in activated stellate cells |
| PPARGC1A | PGC-1alpha, a mitochondrial biogenesis regulator | Linked to metabolic adaptation during CCl4-induced fibrosis |
How Is carbon tetrachloride metabolic process Regulated?
Carbon tetrachloride metabolic process is regulated at multiple levels. The availability and activity of cytochrome P450 enzymes, particularly CYP2E1, determine the rate of reductive dehalogenation and radical formation. Because metabolic activation damages cytochrome P450 itself, enzyme inactivation provides a negative feedback that limits further CCl4 bioactivation. Host metabolic status also regulates the downstream consequences of CCl4 metabolism: in ob/ob mice, downregulation of lipocalin-2 protein was associated with the absence of CCl4-promoted hepatic fibrosis, indicating that adipokine signaling modulates the fibrotic response. In hepatic stellate cells, AMPK activity and mitophagy-induced metabolic reprogramming are required to maintain the activated state that drives fibrosis after CCl4 injury. Antioxidant pathways, including glutathione-dependent enzymes and NRF2 target genes, counterbalance the oxidative stress generated by CCl4 metabolism and thereby modulate overall toxicity.
carbon tetrachloride metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP2E1 | CCl4-induced hepatotoxicity and oxidative liver injury | Cyp2e1 knockout mice treated with CCl4 |
| LCN2 | Resistance to CCl4-induced hepatic fibrosis in obesity | ob/ob mice with Lcn2 knockdown or knockout |
| AMPK | Hepatic stellate cell activation and fibrosis | Stellate cell-specific AMPK knockout or point-mutation models |
| COL1A1 | Liver fibrosis and extracellular matrix deposition | Reporter knock-in mice for collagen expression after CCl4 |
| IL6 | Inflammatory ovarian damage after CCl4 exposure | CCl4-treated rodent ovary models with Il6 perturbation |
Carbon Tetrachloride Metabolism and Liver Injury
The most extensively studied disease association of GO:0018885 is acute and chronic liver injury. Reductive dehalogenation of CCl4 by cytochrome P450 enzymes generates a trichloromethyl radical that initiates lipid peroxidation and covalent binding, leading to hepatocellular necrosis and steatosis. CCl4 is therefore a standard experimental hepatotoxin used to model liver damage and to test hepatoprotective compounds, including plant-derived extracts such as Olea europaea leaf preparations. The severity of injury depends on the balance between bioactivation and antioxidant defense, and on host factors such as lipocalin-2.
Hepatic Fibrosis and Stellate Cell Activation
Repeated CCl4 exposure drives hepatic fibrosis through activation of hepatic stellate cells and deposition of extracellular matrix proteins such as type I collagen. In ob/ob mice, CCl4 did not promote hepatic fibrosis, and this resistance was linked to downregulation of lipocalin-2 protein, highlighting the role of metabolic context in fibrogenesis. AMPK maintains the activated state of hepatic stellate cells through mitophagy-induced metabolic reprogramming, providing a mechanistic link between cellular energetics and fibrosis progression after CCl4 injury. These findings make GO:0018885 a useful entry point for studying fibrosis mechanisms and candidate therapeutic targets.
Extrahepatic Toxicity: Ovarian Damage
Carbon tetrachloride exposure is not limited to the liver. In experimental models, CCl4 exposure induced ovarian damage through oxidative stress and inflammatory mediated ovarian fibrosis, demonstrating that GO:0018885-related chemistry can affect reproductive tissues. This extrahepatic toxicity broadens the disease relevance of the term and suggests that antioxidant and anti-inflammatory strategies may be relevant for protecting multiple organ systems after CCl4 exposure.
Environmental and Biotechnological Implications
Beyond human disease, carbon tetrachloride metabolic process is relevant to environmental health because CCl4 is a persistent chlorinated contaminant. Aerobic transformation by poplar cells and anaerobic transformation under sulfate-reducing conditions demonstrate that biological systems can degrade CCl4, informing bioremediation strategies. Understanding these pathways supports risk assessment and the development of biological cleanup approaches for contaminated sites.
From carbon tetrachloride metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene mediate CCl4 bioactivation? | Cytochrome P450 knockout or point-mutation cell lines |
| Does a gene modify CCl4-induced fibrosis? | Knockout or overexpression in hepatic stellate cells and rodent models |
| Is a gene required for antioxidant defense against CCl4? | CRISPR knockout of antioxidant genes followed by CCl4 treatment |
| Does a variant alter CCl4 metabolism kinetics? | Point-mutation knock-in of the target enzyme |
| Can a gene product be tracked during CCl4 injury? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression protect against CCl4 toxicity? | Stable overexpression cell models and transgenic animals |
How to Study the carbon tetrachloride metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Microsomal incubation with CCl4 | Reductive dehalogenation activity and cytochrome P450 loss | Enzyme kinetics and bioactivation studies |
| Lipid peroxidation assay | Malondialdehyde and related oxidation products | Oxidative stress assessment after CCl4 exposure |
| Antioxidant enzyme activity assay | Glutathione peroxidase, catalase, superoxide dismutase activity | Cellular defense profiling |
| RNA sequencing | Transcriptional changes after CCl4 treatment | Pathway discovery and biomarker identification |
| Proteomics | Protein abundance and modification changes | Identification of modifiers such as lipocalin-2 |
| Histopathology | Necrosis, steatosis, and fibrosis in tissue sections | Phenotypic validation in rodent models |
| CRISPR knockout screening | Genes required for CCl4 sensitivity or resistance | Causal gene discovery |
| Reporter knock-in imaging | Real-time localization of tagged proteins | Tracking stellate cell activation and metabolic reprogramming |
Biochemical Assays of CCl4 Metabolism
Direct measurement of carbon tetrachloride metabolic process typically uses hepatic microsomes or recombinant cytochrome P450 systems incubated with CCl4, followed by detection of metabolites, chloride release, or radical adducts. The apparent loss of cytochrome P-450 during metabolic activation can be monitored spectrophotometrically as an index of bioactivation. These assays are foundational for characterizing enzyme kinetics and inhibitor sensitivity.
Oxidative Stress and Lipid Peroxidation Readouts
Because CCl4 metabolism generates reactive radicals, lipid peroxidation products such as malondialdehyde and 4-hydroxynonenal are commonly measured as biomarkers. Antioxidant enzyme activities, including glutathione peroxidase, catalase, and superoxide dismutase, provide complementary information on cellular defense status. Histological assessment of necrosis and steatosis links biochemical changes to tissue pathology.
Transcriptomic and Proteomic Profiling
RNA sequencing and proteomics can identify genes and proteins whose expression changes after CCl4 exposure, revealing pathways that cooperate with or counteract GO:0018885. In ob/ob mice, proteomic analysis identified lipocalin-2 downregulation as a correlate of resistance to CCl4-induced fibrosis. In hepatic stellate cells, metabolic reprogramming and mitophagy-related proteins have been mapped using similar approaches.
Genetic and CRISPR-Based Perturbation
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in the CCl4 metabolic process. For example, knocking out a cytochrome P450 isoform can reduce radical formation, while overexpressing an antioxidant enzyme can attenuate injury. These approaches connect specific genes to the metabolic and pathological outcomes of CCl4 exposure.
How CRISPR Can Be Used to Study GO:0018885 carbon tetrachloride metabolic process
Knockout
CRISPR knockout models are used to delete candidate genes involved in carbon tetrachloride metabolic process, such as cytochrome P450 isoforms or antioxidant enzymes, to test whether they are required for radical formation or protection against oxidative damage. Knockout of Lcn2 in obese mice can probe its role in resistance to CCl4-induced fibrosis. These models provide causal evidence linking specific genes to the metabolic and pathological outcomes of CCl4 exposure.
Point Mutation
Point-mutation knock-in can be used to alter catalytic residues or regulatory phosphorylation sites in enzymes and signaling proteins involved in CCl4 metabolism and its downstream responses. For example, mutating the active site of a cytochrome P450 can reduce radical generation, while mutating AMPK phosphorylation sites can test its role in stellate cell activation. Such models refine mechanistic understanding beyond simple loss-of-function.
Knock-in
Knock-in of reporter tags or humanized alleles allows tracking of proteins involved in CCl4 metabolism in live cells and tissues. Tagged knock-in of collagen or alpha-smooth muscle actin enables real-time monitoring of fibrogenic responses after CCl4 injury. Humanized knock-in models can also be used to study species-specific differences in xenobiotic metabolism.
Overexpression
Overexpression models test whether increasing the abundance of a candidate protein protects against or exacerbates CCl4 toxicity. Overexpressing antioxidant enzymes such as glutathione peroxidase or heme oxygenase-1 can attenuate lipid peroxidation and injury. Conversely, overexpressing bioactivating enzymes may increase radical formation and tissue damage, providing a sensitive readout of GO:0018885 activity.
How EDITGENE Supports carbon tetrachloride metabolic process Research
Researchers studying carbon tetrachloride metabolic process-related genes often need to determine whether a candidate gene is causally involved in bioactivation, oxidative stress, or fibrosis, rather than merely correlated with exposure. EDITGENE provides the CRISPR tools and cell models required to move from association to causation, enabling precise perturbation of genes implicated in GO:0018885 and its downstream pathology.
Contact EDITGENE today to design your custom CRISPR model for carbon tetrachloride metabolic process research.
Frequently Asked Questions About carbon tetrachloride metabolic process
What is carbon tetrachloride metabolic process (GO:0018885)?
It is the biological process comprising the chemical reactions and pathways involving carbon tetrachloride, a toxic and carcinogenic solvent, as defined by the Gene Ontology.
What genes are involved in carbon tetrachloride metabolic process?
Key genes include cytochrome P450 isoforms such as CYP2E1 that reductively dehalogenate CCl4, as well as antioxidant and fibrosis-related genes such as LCN2, AMPK, COL1A1, and ACTA2.
How does carbon tetrachloride cause liver damage?
Cytochrome P450 enzymes convert CCl4 to a trichloromethyl radical that initiates lipid peroxidation and covalent binding to macromolecules, leading to hepatocellular injury.
Is carbon tetrachloride metabolism only relevant to the liver?
No. CCl4 exposure can also cause ovarian damage through oxidative stress and inflammatory fibrosis, and it can be transformed by plant cells and anaerobic microbial communities.
What is the role of lipocalin-2 in CCl4-induced fibrosis?
In ob/ob mice, downregulation of lipocalin-2 protein was associated with the absence of CCl4-promoted hepatic fibrosis, indicating that it modulates fibrotic responses.
How is AMPK involved in CCl4-induced fibrosis?
AMPK maintains the activated state of hepatic stellate cells through mitophagy-induced metabolic reprogramming, linking cellular energetics to fibrosis progression.
Can plants metabolize carbon tetrachloride?
Yes, poplar cells have been shown to aerobically transform carbon tetrachloride, demonstrating that plant systems possess relevant metabolic capacity.
What experimental models are used to study carbon tetrachloride metabolic process?
Common models include rodent liver injury models, ob/ob mice, rat ovarian injury models, poplar cell cultures, and sulfate-reducing microbial communities.
How can CRISPR help study carbon tetrachloride metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in CCl4 bioactivation, oxidative stress, and fibrosis.
What are the main oxidative stress markers after CCl4 exposure?
Lipid peroxidation products such as malondialdehyde, along with changes in glutathione peroxidase, catalase, and superoxide dismutase activities, are commonly measured.
Conclusion
GO:0018885 carbon tetrachloride metabolic process provides a precise ontological framework for studying how a toxic halogenated solvent is transformed by living systems. The process is initiated by cytochrome P450-mediated reductive dehalogenation, which generates a reactive trichloromethyl radical that drives lipid peroxidation, covalent adduct formation, and organ injury. Its consequences extend beyond the liver to reproductive tissues and are modulated by host metabolic factors such as lipocalin-2 and AMPK-dependent stellate cell reprogramming. Because CCl4 remains a standard experimental hepatotoxin and an environmental contaminant, understanding its metabolic process has both biomedical and biotechnological value. CRISPR-based knockout, point-mutation, knock-in, overexpression, and library screening approaches offer powerful ways to dissect the genes that control CCl4 bioactivation and its downstream pathology, supporting the development of protective strategies and improved risk assessment.
References
- 1. Brattin WJ et al.. 1985. Pathological mechanisms in carbon tetrachloride hepatotoxicity.. J Free Radic Biol Med 1(1):27-38 PMID: 3915301
- 2. Shin HJ et al.. 2025. Carbon tetrachloride does not promote hepatic fibrosis in ob/ob mice via downregulation of lipocalin-2 protein.. Redox Biol 80:103506 PMID: 39832399
- 3. Wang X et al.. 2002. Mechanism of aerobic transformation of carbon tetrachloride by poplar cells.. Biodegradation 13(5):297-305 PMID: 12688582
- 4. Xue L et al.. 2022. Carbon tetrachloride exposure induces ovarian damage through oxidative stress and inflammatory mediated ovarian fibrosis.. Ecotoxicol Environ Saf 242:113859 PMID: 35816842
- 5. Wang H et al.. 2026. AMPK maintains the activation of hepatic stellate cells through mitophagy-induced metabolic reprogramming.. J Mol Cell Biol 17(7) PMID: 40905731
- 6. Memon AA et al.. 2024. The hepatoprotective potentials of Olea europaea L. leaves against carbon tetrachloride-induced hepatic injury in rats.. J Pak Med Assoc 74(1 (Supple-2)):S63-S67 PMID: 38385474
- 7. de Best JH et al.. 1997. Transformation of carbon tetrachloride under sulfate reducing conditions.. Biodegradation 8(6):429-36 PMID: 15765588
- 8. Yamazoe Y et al.. 1979. The apparent loss of cytochrome P-450 associated with metabolic activation of carbon tetrachloride.. Jpn J Pharmacol 29(5):715-21 PMID: 43918
